Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Ask our office staff for assistance with any paperwork or prior authorization that may be required
Or is there really no risk at all
Participants, stratified by geographic region, T2D status and fibrosis stage, were randomized to receive semaglutide at a maximum dose of 0.1 mg ( n = 80), 0.2 mg ( n = 78) or 0.4 mg ( n = 82) or placebo ( n = 80) via once-weekly subcutaneous injection for 72 weeks
27.2% of participants lost more than 10% of starting weight across three studies
Individual weight-loss is dependent on a number of factors but on average patients using GLP-1 medications lose around 1.5% of their body weight per week
Epub 2021 Jun 1
US$ 28.12
US$ 21.87
US$ 21.90
US$ 22.89
US$ 28.09
US$ 26.09
US$ 23.46
